Stockreport

Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes [Yahoo! Finance]

Abbott Laboratories  (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
PDF This significant decrease is linked to the use of Libre biowearable technology compared to traditional blood glucose monitors. Results also show a reduction in hospit [Read more]